Cargando…

EP1269: INTERIM ANALYSIS OF A MULTICENTER REGISTRY STUDY OF COVID-19 INFECTED PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN JAPAN (J-COSMOS).

Detalles Bibliográficos
Autores principales:	Hayashi, Yuki, Nakase, Hiroshi, Hirayama, Daisuke, Matsumoto, Takayuki, Matsuura, Minoru, Iijima, Hideki, Matsuoka, Katsuyoshi, Ohmiya, Naoki, Ishihara, Shunji, Hirai, Fumihito, Hisamatsu, Tadakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212388/ http://dx.doi.org/10.1016/S0016-5085(22)62592-7

Ejemplares similares

Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)
por: Nakase, Hiroshi, et al.
Publicado: (2022)

Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES
por: Watanabe, Kenji, et al.
Publicado: (2022)

Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
por: Nakase, Hiroshi, et al.
Publicado: (2023)

EP1277: EFFICACY OF CARBON DIOXIDE INSUFFLATION DURING COLONOSCOPY FOR PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION -A RANDOMIZED TRIAL-
por: Otake, Yuriko, et al.
Publicado: (2022)

EP1272: DIETARY LIPIDS FUEL METABOLIC ENTERITIS IN CROHN'S DISEASE
por: Schwärzler, Julian, et al.
Publicado: (2022)

EP1270: SEROCONVERSION IN INFLAMMATORY BOWEL DISEASE PATIENTS AFTER COVID-19 VACCINATION
por: Horvath, Miklos, et al.
Publicado: (2022)

EP1019: THE EFFECTS OF THE COVID-19 PANDEMIC ON PRESENTATIONS AND DIAGNOSIS OF UPPER GI AND HEPATOPANCREATICOBILIARY MALIGNANCIES
por: Carroll, Andrew, et al.
Publicado: (2022)

EP1018: GASTROINTESTINAL BLEEDING DURING THE COVID-19 PANDEMIC: IMPACT ON PATIENT PRESENTATION AND OUTCOMES
por: Kerbage, Anthony, et al.
Publicado: (2022)

EP1020: THE PREVALENCE OF GASTROINTESTINAL SYMPTOMS IN ACUTE COVID-19 INFECTION EVALUATED WITH A DIGITAL QUESTIONNAIRE
por: Malderen, Kathleen Van, et al.
Publicado: (2022)

EP1017: CHANGING PERFORMANCE OF COLORECTAL CANCER SCREENING FOLLOWING A COVID-19 PANDEMIC IN KOREA
por: Kim, Hyun-Soo, et al.
Publicado: (2022)

Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey
por: Nakase, Hiroshi, et al.
Publicado: (2023)

EP1021: CHANGES IN THE NEEDS OF IBD PATIENTS FOR TREATMENT BEFORE AND AFTER THE COIVD19 EPIDEMIC (ANALYSIS USING TWITTER DATA)
por: Fuchigami, Ayako
Publicado: (2022)

EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE
por: Shiga, Hisashi, et al.
Publicado: (2022)

EP1273: PRACTICAL APPLICATION OF EVIDENCE-BASED DIETARY THERAPY INTO INFLAMMATORY BOWEL DISEASE CARE. PATIENT SATISFACTION, COMPLIANCE, AND EFFICACY. THE DELECTABLE PROGRAM.
por: Russell, Erin, et al.
Publicado: (2022)

EP1278: EFFICACY OF TOTAL ENTERAL NUTRITION COMBINED WITH AZATHIOPRINE IN MAINTAINING POSTOPERATIVE REMISSION IN CROHN'S DISEASE: A PARALLEL, RANDOMIZED CONTROLLED STUDY
por: Duan, Ming, et al.
Publicado: (2022)

Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2023)

EP1271: UNPLANNED HOPSITAL ADMISSION AND EMERGENCY ATTENDANCE FOLLOWING TWO-DOSE OF BNT162B2 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED COHORT STUDY
por: Li, Xue, et al.
Publicado: (2022)

Machine learning using clinical data at baseline predicts the efficacy of vedolizumab at week 22 in patients with ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2021)

miR-1269a and miR-1269b: Emerging Carcinogenic Genes of the miR-1269 Family
por: Xie, Zijun, et al.
Publicado: (2022)

Diagnosis and management of intestinal Behçet’s disease
por: Hisamatsu, Tadakazu, et al.
Publicado: (2014)

Sa571 EVALUATION OF MENTAL STATE AND CLINICAL SYMPTOMS OF CORONAVIRUS PANDEMIC IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Tani, Mizuki, et al.
Publicado: (2021)

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
por: Kanai, Takanori, et al.
Publicado: (2014)

Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2022)

Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
por: Nakase, Hiroshi, et al.
Publicado: (2021)

Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
por: Yamamoto, Takayuki, et al.
Publicado: (2023)

Should We Continue or Discontinue Inflammatory Bowel Disease Medication in Patients With Coronavirus Disease 2019?
por: Hayashi, Yuki, et al.
Publicado: (2022)

Adrenomedullin for biologic‐resistant Crohn's disease: A randomized, double‐blind, placebo‐controlled phase 2a clinical trial
por: Kita, Toshihiro, et al.
Publicado: (2022)

AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
por: Grover, Shilpa, et al.
Publicado: (2020)

Su1187 ALMOST EVERYTHING CAUSES DIARRHEA: GASTROINTESTINAL MANIFESTATIONS OF ACUTE RESPIRATORY INFECTIONS AMONG 3,510 INDIVIDUALS IN A COMMUNITY-BASED STUDY
por: Newman, Kira L., et al.
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

Sa101 INCREASING THE LOW-RISK THRESHOLD FOR PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING DURING THE COVID-19 PANDEMIC: A PROSPECTIVE, MULTICENTRE, FEASIBILITY STUDY
por: Dunne, Philip, et al.
Publicado: (2021)

Sa002 IMPACT OF THE COVID-19 PANDEMIC ON A LARGE ORGANIZED COLORECTAL CANCER SCREENING PROGRAM BASED ON FECAL IMMUNOCHEMICAL TESTING AND OPPORTUNISTIC COLONOSCOPY
por: Levin, Theodore R., et al.
Publicado: (2021)

Sa003 COVID-19 PANDEMIC AND REDUCTION OF COLORECTAL CANCER SCREENING RELATED PROCEDURES IN THE CZECH REPUBLIC
por: Suchanek, Stepan, et al.
Publicado: (2021)

Sa004 DECLINING COLORECTAL CANCER SCREENING IN THE AGE OF COVID-19
por: Torres, Jon Alexander, et al.
Publicado: (2021)

Fr089 IMPACT OF COVID-19 ON PANDEMIC MAJOR GASTROENTEROLOGY PROCEDURES, VISITS, AND NEW DIAGNOSIS OF GASTROINTESTINAL CANCERS
por: Khan, Ahmad, et al.
Publicado: (2021)

Sa504 INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN SOUTH ASIAN AND CHINESE PEOPLE: A POPULATION-BASED COHORT STUDY FROM ONTARIO, CANADA
por: Dhaliwal, Jasbir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_avlrdlfhu4afbaklmup57pesrq